(CBK) Commerzbank - Ratings and Ratios
Loans, Accounts, Cards, Trade Finance, Asset Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.82% |
| Yield on Cost 5y | 13.05% |
| Yield CAGR 5y | 15.02% |
| Payout Consistency | 45.1% |
| Payout Ratio | 28.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 30.9% |
| Value at Risk 5%th | 47.8% |
| Relative Tail Risk | -5.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.37 |
| Alpha | 128.98 |
| CAGR/Max DD | 2.34 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.451 |
| Beta | 0.222 |
| Beta Downside | 0.463 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.68% |
| Mean DD | 8.08% |
| Median DD | 7.15% |
Description: CBK Commerzbank December 04, 2025
Commerzbank AG (XETRA: CBK) is a German-headquartered universal bank that serves private-individuals, small-business owners, corporates, financial-service firms and institutional investors across Europe, the Americas and Asia. Its operations are split into two segments – Private & Small-Business Customers and Corporate Clients – delivering a full suite of retail banking products (savings, checking, credit/debit cards, loans, pension and payment solutions) and corporate services (real-estate financing, M&A advisory, trade finance, securities trading, wealth and asset management).
Key recent metrics indicate the bank is navigating a challenging European banking environment: the CET1 capital ratio stood at roughly 13.5 % at year-end 2023, while the cost-to-income ratio improved to about 65 % after a multi-year efficiency program. Net interest income benefited from the ECB’s rate hikes in 2023-24, lifting the net interest margin by ~15 bps, and loan growth remained modest at ~2 % YoY. A sector-wide driver is the ongoing digital transformation, with Commerzbank reporting a 12 % YoY increase in online transaction volume, which is critical for sustaining fee income as traditional margins tighten.
If you want to dig deeper into how these drivers translate into valuation upside or downside for CBK, a quick look at ValueRay’s analytical dashboards can provide a data-rich perspective.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (2.64b TTM) > 0 and > 6% of Revenue (6% = 1.31b TTM) |
| FCFTA -0.04 (>2.0%) and ΔFCFTA -7.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1555 % (prev 816.5%; Δ -2372 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.03 (>3.0%) and CFO -18.14b <= Net Income 2.64b (YES >=105%, WARN >=100%) |
| Net Debt (-24.24b) to EBITDA (2.86b) ratio: -8.48 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.13b) change vs 12m ago -4.83% (target <= -2.0% for YES) |
| Gross Margin 60.29% (prev 48.17%; Δ 12.12pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 3.76% (prev 4.41%; Δ -0.65pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.25 (EBITDA TTM 2.86b / Interest Expense TTM 11.44b) >= 6 (WARN >= 3) |
Altman Z'' -3.57
| (A) -0.57 = (Total Current Assets 89.93b - Total Current Liabilities 428.75b) / Total Assets 592.95b |
| (B) 0.03 = Retained Earnings (Balance) 19.39b / Total Assets 592.95b |
| (C) 0.00 = EBIT TTM 2.89b / Avg Total Assets 579.14b |
| (D) 0.04 = Book Value of Equity 20.51b / Total Liabilities 558.63b |
| Total Rating: -3.57 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.85
| 1. Piotroski 5.0pt |
| 2. FCF Yield -85.38% |
| 3. FCF Margin -98.51% |
| 4. Debt/Equity 1.60 |
| 5. Debt/Ebitda -8.48 |
| 6. ROIC - WACC (= -2.86)% |
| 7. RoE 7.67% |
| 8. Rev. Trend 44.06% |
| 9. EPS Trend 62.78% |
What is the price of CBK shares?
Over the past week, the price has changed by +1.16%, over one month by +9.74%, over three months by +9.23% and over the past year by +136.28%.
Is CBK a buy, sell or hold?
What are the forecasts/targets for the CBK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.9 | -5.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 56.8 | 58.9% |
CBK Fundamental Data Overview December 19, 2025
Market Cap EUR = 39.52b (39.52b EUR * 1.0 EUR.EUR)
P/E Trailing = 16.9324
P/E Forward = 12.5313
P/S = 3.4911
P/B = 1.1342
P/EG = 1.3922
Beta = 0.636
Revenue TTM = 21.79b EUR
EBIT TTM = 2.89b EUR
EBITDA TTM = 2.86b EUR
Long Term Debt = 53.33b EUR (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 54.89b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -24.24b EUR (from netDebt column, last fiscal year)
Enterprise Value = 25.14b EUR (39.52b + Debt 54.89b - CCE 69.27b)
Interest Coverage Ratio = 0.25 (Ebit TTM 2.89b / Interest Expense TTM 11.44b)
FCF Yield = -85.38% (FCF TTM -21.46b / Enterprise Value 25.14b)
FCF Margin = -98.51% (FCF TTM -21.46b / Revenue TTM 21.79b)
Net Margin = 12.11% (Net Income TTM 2.64b / Revenue TTM 21.79b)
Gross Margin = 60.29% ((Revenue TTM 21.79b - Cost of Revenue TTM 8.65b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 55.18%)
Tobins Q-Ratio = 0.04 (Enterprise Value 25.14b / Total Assets 592.95b)
Interest Expense / Debt = 5.07% (Interest Expense 2.79b / Debt 54.89b)
Taxrate = 36.42% (374.0m / 1.03b)
NOPAT = 1.84b (EBIT 2.89b * (1 - 36.42%))
Current Ratio = 0.21 (Total Current Assets 89.93b / Total Current Liabilities 428.75b)
Debt / Equity = 1.60 (Debt 54.89b / totalStockholderEquity, last quarter 34.32b)
Debt / EBITDA = -8.48 (Net Debt -24.24b / EBITDA 2.86b)
Debt / FCF = 1.13 (negative FCF - burning cash) (Net Debt -24.24b / FCF TTM -21.46b)
Total Stockholder Equity = 34.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.45% (Net Income 2.64b / Total Assets 592.95b)
RoE = 7.67% (Net Income TTM 2.64b / Total Stockholder Equity 34.40b)
RoCE = 3.29% (EBIT 2.89b / Capital Employed (Equity 34.40b + L.T.Debt 53.33b))
RoIC = 1.87% (NOPAT 1.84b / Invested Capital 97.98b)
WACC = 4.73% (E(39.52b)/V(94.40b) * Re(6.83%) + D(54.89b)/V(94.40b) * Rd(5.07%) * (1-Tc(0.36)))
Discount Rate = 6.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -4.65%
Fair Price DCF = unknown (Cash Flow -21.46b)
EPS Correlation: 62.78 | EPS CAGR: 11.70% | SUE: -0.35 | # QB: 0
Revenue Correlation: 44.06 | Revenue CAGR: -8.16% | SUE: -0.11 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.77 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=3.03 | Chg30d=+0.021 | Revisions Net=+4 | Growth EPS=+22.5% | Growth Revenue=+8.1%